These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 998736)
1. Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. Larsson LI; Schwartz T; Lundqvist G; Chance RE; Sundler F; Rehfeld JF; Grimelius L; Fahrenkrug J; Schaffalitzky de Muckadell O; Moon N Am J Pathol; 1976 Dec; 85(3):675-84. PubMed ID: 998736 [TBL] [Abstract][Full Text] [Related]
2. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor. Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208 [TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal polypeptide: elevated plasma and tissue levels in the watery-diarrhea syndrome due to pancreatic and other tumors. Said SI Trans Assoc Am Physicians; 1975; 88():87-93. PubMed ID: 1224442 [No Abstract] [Full Text] [Related]
4. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue. Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608 [TBL] [Abstract][Full Text] [Related]
5. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor. Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230 [TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448 [TBL] [Abstract][Full Text] [Related]
8. Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. Said SI; Faloona GR N Engl J Med; 1975 Jul; 293(4):155-60. PubMed ID: 166313 [TBL] [Abstract][Full Text] [Related]
9. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors. Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic-polypeptide (PP) and endocrine tumours of the pancreas. Schwartz TW Scand J Gastroenterol Suppl; 1979; 53():93-100. PubMed ID: 225793 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of the endocrine cells in the pancreas of the carp, Cyprinus carpio (Cyprinidae). Kong HS; Lee JH; Park KD; Ku SK; Lee HS J Vet Sci; 2002 Dec; 3(4):303-14. PubMed ID: 12819380 [TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of the pancreatic endocrine cells of the nude mouse, Balb/c-nu/nu. Ku SK; Lee HS Eur J Histochem; 2006; 50(1):61-8. PubMed ID: 16584986 [TBL] [Abstract][Full Text] [Related]
19. [VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome]. Kunert H; Kuhn FM; Schwemmle K; Ottenjann R Dtsch Med Wochenschr; 1976 Jun; 101(24):920-3. PubMed ID: 179772 [TBL] [Abstract][Full Text] [Related]
20. Vipoma of the pancreas: observations on the diarhrhea and circulatory disturbances. Barraclough MA; Bloom SR Arch Intern Med; 1979 Apr; 139(4):467-71. PubMed ID: 435002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]